Bortolotti U, Milano A, Thiene G, Mazzucco A
Department of Cardiovascular Surgery, University of Padova Medical School, Italy.
Eur J Cardiothorac Surg. 1992;6 Suppl 1:S75-8.
The standard (glutaraldehyde-preserved) Hancock porcine bioprosthesis was introduced into clinical practice in order to provide surgeons with a cardiac valve substitute which would be nonthrombogenic and therefore would not require anticoagulation, and would be durable, anatomically suitable, and noiseless. In the present report we have reviewed our long-term experience with Hancock porcine valve recipients in order to verify the original expectations of this bioprosthesis have been met.
标准的（经戊二醛保存的）汉考克猪生物假体被引入临床实践，目的是为外科医生提供一种心脏瓣膜替代品，该替代品不会形成血栓，因此不需要抗凝，并且耐用、在解剖学上合适且无噪音。在本报告中，我们回顾了我们在汉考克猪瓣膜接受者方面的长期经验，以验证这种生物假体是否达到了最初的期望。
